- Petco Health And Wellness Co Inc WOOF is down over 15% during Wednesday's session following its mixed Q4 performance and lackluster FY23 outlook.
- WOOF reported fourth-quarter FY22 sales growth of 4.2% year-on-year to $1.577 billion, marginally above the consensus of $1.570 billion.
- Comparable sales climbed 5.3% versus last year and 18.8% on a two-year basis.
- Gross profit decreased 1% Y/Y to $627.3 million, with a profit margin of 39.7%.
- Operating margin was 4.9%, and operating income for the quarter fell 6% to $77.6 million.
- Adjusted EBITDA decreased 1.1% Y/Y to $170.3 million.
- Adjusted EPS of $0.23 missed the analyst consensus of $0.24.
- Petco held $201.9 million in cash and equivalents as of Jan. 28, 2023. Cash provided by operating activities for the quarter totaled $136.5 million, with a free cash flow of $70.6 million.
- Outlook: Petco expects FY23 net sales of $6.15 billion - $6.275 billion versus the Street view of $6.36 billion.
- The company sees FY23 adjusted EPS down $0.21 - down $0.13.
- In Fiscal 2023, the company expects to make a total of $100 million in principal payments on its term loan, including the $35 million paid in March.
- Also Read: Freshpet, Petco Health Launch Customized Fresh Pet Food Subscription Delivered To Pet Parents' Doors
- Price Action: WOOF shares are trading lower by 7.28% at $9.43 in premarket on the last check Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in